STUDY SEARCH RESULTS

1 study found for your search request:  V116-013

A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013)
Condition: Pneumococcal Infection
Minimum Age: 2 years, Maximum Age: 17 years
Gender: All
Study ID: NCT06177912
Status: Recruiting
Has Enrolling Locations in US or Canada




Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  U.S. Corporate Site